Sign in
CompletedNo phase

Role of Exercise in Chronic Liver Disease Patients Undergoing Liver Transplantation

Key facts

Who runs it
Institute of Liver and Biliary Sciences, India
Where
India1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
60 people enrolled
Started
15 Dec 2023
Ended
31 Jan 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Supervised aerobic and resistance exercises
  • Dietary supplementation
Record updated
24 August 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Voluntary adult patient (>18 years), decompensated chronic liver disease patients planned for LDLT, and Who pass the screening tests done in the OPD; Able to follow the introductory level exercises as per the protocol in the OPD without any adverse event; No drop in the spO2 less than 93% on a 6 minute walk test

Who cannot take part

  • Patients on the following drugs-; Higher corticosteroid dose (>0.1mg/kg/day),; BCAA (Branched chain amino acids); Growth hormone, testosterone, SARMs,; Ghrelin agonists, myostatin antibodies,; Activin IIR antagonists, angiotensin converting enzyme inhibitors,; Espindolol (mixed beta agonist and antagonists), and; Fast skeletal muscle troponin activators
  • Patients with a physical disability (upper or lower limb deformity/abnormality)
  • Exercise intolerance or inability to follow exercise regime
  • Patients who fail the screening tests

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this randomised clinical trial (open label) is to test the effect of supervised aerobic and resistance exercises in chronic liver disease patients being planned for living donor liver transplantation (LDLT). The main question it aims to answer are:

Read full original descriptionShow less

* If pre-operative supervised aerobic and resistance exercise for 4 weeks can improve the measures of frailty (Liver frailty index, Short physical performance battery, pulmonary function tests) in chronic liver disease patients being planned for LDLT. * Can this approach also translate into clinically significant benefits in the postoperative outcomes of LDLT.

Participants will be randomised into two groups receiving either

1. Standard medical therapy along with supervised aerobic and resistance exercises for 4 weeks. 2. Standard medical therapy. The two groups will be compared for progression of the measures of frailty ver the course of their participation as well as their post LDLT outcomes.

The 2 groups in the trial

  • Exercise GroupTreatment being tested

    Treatment: Supervised aerobic and resistance exercises and Dietary supplementation

  • Dietary supplementationExisting treatment, for comparison

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effects of Supervised Aerobic and Resistance Exercises on Measures of Frailty in Chronic Liver Disease Patients Undergoing Living Donor Liver Transplantation- an Open Label Randomised Controlled Trial
Record updated
24 August 2025